Food and Drug Administration (FDA). This designation marks an important regulatory milestone for Gene Solutions and reflects the continued progress of SPOT-MAS as an AI-powered, multi-omic platform for early cancer detection.
SPOT-MAS Multi-Cancer Screening Test Receives U.S. FDA Breakthrough Device Designation
The proposed indications for use describe SPOT-MAS 10 as a qualitative in vitro diagnostic test performed on plasma derived from a single direct-draw venous whole blood specimen. The test analyzes circulating cell-free DNA methylation and fragmentomic signatures using a machine-learning-based algorithm to detect a cancer-associated signal. It is intended for use as an adjunctive screening test in asymptomatic adults aged 40 years and older to assist in detecting cancers within the scope of the assay. These include five common cancers — breast, lung, liver, colorectal and gastric cancers — and five aggressive, less common cancers that currently lack standard screening methods — ovarian, pancreatic, esophageal, endometrial and head & neck cancers.
SPOT-MAS has been developed through years of rigorous scientific research and clinical development. In March 2025, SPOT-MAS became the first multi-cancer screening blood test in Asia to complete a large prospective cohort validation, with the K-DETEK study evaluating more than 9,000 asymptomatic participants and demonstrating strong performance, including high specificity and the ability to identify cancer-associated signals across multiple cancer types.
Since then, SPOT-MAS has been used in more than 100,000 individuals in real-world practice, with consistent performance observed beyond controlled study settings. Real-world data were presented at ESMO Asia 2025 and were featured at ASCO Breakthrough 2026 in Singapore.
The platform is built on a multi-omic approach— integrating genetics, epigenetics, and fragmentomics — together with AI-driven analysis, large-scale prospective validation, growing real-world evidence and focus on cancer types with high clinical relevance in the regions where the test is deployed.
For the United States, Breakthrough Device Designation provides Gene Solutions with a prioritized channel of engagement with the FDA as the company advances its U.S. development and validation plans.
Looking ahead, Gene Solutions will continue to collaborate with academic, clinical, laboratory, commercial and strategic partners to support responsible adoption of SPOT-MAS in accordance with local regulations, clinical guidelines and best practices.
Important Regulatory Notice: SPOT-MAS 10 has received U.S. FDA Breakthrough Device Designation. Breakthrough Device Designation is not FDA approval, clearance or marketing authorization. The device remains subject to applicable FDA regulatory review requirements, and the designation does not guarantee future FDA approval, clearance or authorization.
For more information, visit https://spotmas.com.hk
Contact: hk.cs@genesolutions.com Source: Gene Solutions Hong Kong Limited. SPOTMAS_062026_04
A long Australian road trip in a caravan can be an exciting adventure. However, choosing the right caravan often feels overwhelming when you start comparing layouts, fe…
Owning several shares doesn’t always mean your portfolio is truly diversified. If those companies respond to the same economic conditions, your returns may still depend…
There was a time when jewellery was the first thing to come off before a workout, beach swim or shower. Today, that's changing.
As our lifestyles become busier and mor…
Choosing an engagement ring is one of the most meaningful decisions a couple will make. Today, more people are looking for beautiful, ethical, and affordable alternatives…
Drive through any established or newly developing suburb in Australia right now and you'll notice a growing number of homes with striking black or charcoal-toned exteri…
Mining is one of the most physically demanding industries in Australia, and it's also one of the most heavily regulated when it comes to worker safety. A single inciden…
Choosing a caravan is a decision that can shape the way you travel for years to come. The number of options available from caravan dealers makes choosing the right layo…
Disagreements between landlords and tenants can develop gradually, sometimes starting with a single unresolved question about money or an obligation described ambiguously…
In clinical settings, surgical supply partners aren’t just vendors. They sit quietly behind the scenes of operating lists, specialist consultations, treatment rooms and recovery workflows. When they...
The early developmental years of a child's life represent a critical window for neurological growth, behavioural shaping, and language acquisition. During this formative phase, the ability to interpre...
Finding the right family dentist in Sydney is one of the most important health decisions you can make for your household. With hundreds of practices spread across the city — from Beecroft to Bondi, Pa...
Hashtag.net.au
